Study on oxidative stress and inflammatory/antioxidant substance levels in autism spectrum disorder.

Morimoto, Masahito; Hashimoto, Toshiaki; Tsuda, Yoshimi; Suenaga, Midori; Nakamura, Toshimi; Katoh, Shinsuke

Morimoto, Masahito; Hashimoto, Toshiaki; Tsuda, Yoshimi; Suenaga, Midori; Nakamura, Toshimi; Katoh, Shinsuke.

Afiliación

Morimoto M; Department of Pharmacy, Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities, Tokushima, Japan.
Hashimoto T; Department of Pediatric Neurology, Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities, Tokushima, Japan.
Tsuda Y; Department of Pediatric Neurology, Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities, Tokushima, Japan.
Suenaga M; Department of Medical Pharmacology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.
Nakamura T; Department of Medical Pharmacology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.
Katoh S; Department of Rehabilitation Medicine, Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities, Tokushima, Japan.

J Chin Med Assoc ; 86(5): 489-493, 2023 05 01.

Article en En | MEDLINE | ID: mdl-36930855

Asunto(s)

Antioxidantes; Trastorno del Espectro Autista; Niño; Humanos; Antioxidantes/metabolismo; Trastorno del Espectro Autista/metabolismo; Proteína C-Reactiva; Estrés Oxidativo; Oxígeno

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastorno del Espectro Autista / Antioxidantes Límite: Child / Humans Idioma: En Revista: J Chin Med Assoc Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google